Dr. Travis Meredith is new AUPO president
September 16th 2009Travis Meredith, MD, has been elected as the new president of the Association of University Professors of Ophthalmology (AUPO), which is composed of department chairmen, residency directors, and research directors of ophthalmology departments in the United States and Canada, according to a prepared statement.
Bausch & Lomb to consolidate its contact lens manufacturing
September 16th 2009Bausch & Lomb intends to consolidate its worldwide contact lens manufacturing and proposes to begin moving most of its global contact lens production to its existing sites in Waterford, Ireland, and Rochester, NY, according to a prepared statement. ??
Allergan, Pieris AG agreement targets anticalin for treatment of ocular disorders
September 16th 2009Pieris AG announced that it has entered into a collaboration agreement with Allergan Inc. that will combine Pieris' proprietary anticalin technology with Allergan's drug delivery and ophthalmic drug development with a goal of developing agents for the treatment of serious ocular disorders.
Ganciclovir ophthalmic gel 0.15% approved by FDA for herpetic keratitis
September 16th 2009Sirion Therapeutics Inc. announced the FDA approval of its new drug application for ganciclovir ophthalmic gel 0.15% (Zirgan) as a treatment for acute herpetic keratitis. The FDA granted orphan drug designation to the gel for this indication in April 2007.
MBA: Is this the right decision for me?
September 15th 2009Many, if not most, ophthalmologists have at least entertained the idea of obtaining a master of business administration degree. This three-part series is designed to provide guidance through the process. The first steps involve the realization of goals, the return on investment, and the application process.
San Francisco unmatched as a travel destination
September 15th 2009San Francisco is nearly synonymous with a high cost of living. The advent and financial success of the early years of the Internet revolution still lures high-income folks to the city by the bay. Property values and household income are among the top in the nation, which enables a profitable restaurant and entertainment scene.
New lens provides high-definition vision benefits
September 15th 2009A new lens has been introduced into the market (iZon SL Lenses in Transitions VI, Ophthonix) that provides an ultraviolet-light-activated, changeable tint that can offer many HD vision benefits, including better vision in low luminance and intermediate contrast conditions.
Pediatric dispensing for any age
September 15th 2009From babies to toddlers to pre-teens, there are many important considerations to implement when you are dispensing to kids. These considerations range from toddler eyes that are sensitive to ultraviolet rays to protective eyewear for your budding athlete.
Kill kinetics of advanced-generation fluoroquinolones compared in study
September 15th 2009An in vitro kill kinetics study evaluated eradication of 18 human ocular Staphylococcus isolates by commercial formulations of gatifloxacin 0.3% (Zymar, Allergan) and moxifloxacin 0.5% (Vigamox, Alcon Laboratories). Gatifloxacin demonstrated superior activity, which may be attributed to the presence of benzalkonium chloride 0.005% in its formulation.